AKBA — Akebia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Akebia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K/A	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	150	90.5	42.9	51.9	185
Net Total Accounts Receivable
Net Total Receivables	51.6	40.3	39.3	34.4	47
Total Inventory
Prepaid Expenses
Total Current Assets	271	185	118	114	253
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	40.6	34.4	16	10.4	4.88
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	529	356	242	221	377
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	261	130	99.9	80.9	163
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	455	351	272	270	344
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	74	5.23	-30.6	-49.2	32.6
Total Liabilities & Shareholders' Equity	529	356	242	221	377
Total Common Shares Outstanding